Illumina Ordered to Pay Syntrix $115.1M for Infringing Patent | GenomeWeb

NEW YORK (GenomeWeb News) – A federal judge has ordered Illumina to pay $115.1 million to Syntrix Biosystems for infringing a patent held by Syntrix Biosystems.

In his decision handed down on Wednesday, Judge Benjamin Settle, US District Court Western District of Washington, ordered Illumina to pay $96 million in damages that a verdict originally slapped on Illumina in March after finding the San Diego company guilty of infringing US Patent No. 6,951,682 held by Syntrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.